Reitan Colleen F
- SEC CIK
- 0001740730
No open-market purchases or sales filed in the past year.
Current role at each company
- MYGN Myriad Genetics IncDirectoras of Jun 5, 2026
- ALNY Alnylam Pharmaceuticals, Inc.Directoras of May 22, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Reitan Colleen F as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ALNY Alnylam Pharmaceuticals, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 (view filing) | Sep 9 | 2 days | Reitan Colleen FDirector | SSale | −18.0K | $467.60 | −$8.42M | −95.9%775 after | 16 lots10b5-1 |
| May 12, 2025 (view filing) | Aug 29-Oct 17, 2024 | 256 daysLate | Reitan Colleen FDirector | PPurchase | +36 | $287.85 | +$10.4K | New position36 after | 2 lots |
| May 12, 2025 (view filing) | Apr 16 | 26 daysLate | Reitan Colleen FDirector | SSale | −36 | $232.86 | −$8.38K | −100.0%0 after |
MYGN Myriad Genetics Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 2024 (view filing) | Sep 3 | 1 day | Reitan Colleen FDirector | SSale | −46.0K | $27.95 | −$1.29M | −52.0%42.5K after | 10b5-1 |